Chemotherapy Infusion Pharmacist
CurrentDeveloped sterile compounding policies and procedures corresponding to FDA observation 483 and to meet the new USP 800 guidelinesConducted root cause analysis and authored deviation reports on 300+ chemotherapy compounding errorsInitiated and led CAPA projects to resolve procedural deficiencies found during the FDA and internal auditsMaintained QA logbooks.